Staar Surgical and Kobe Kanagawa Eye Clinic, with locations in Tokyo and Osaka, announced they have entered into a multi-year Strategic Cooperation Agreement to provide Staar’s EVO Visian ICL lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refractive eye treatment.
“We are very excited that our clinic has become a strategic partner with Staar Surgical Company and expect to introduce the ICL to many more patients,” Dr. Junki Sawai, Chairman of Kobe Kanagawa Eye Clinic, said in a company news release. “Our clinic has performed almost 500,000 refractive surgery procedures and has implanted the most ICL lenses in Japan for the past 8 years in a row. As a result of this agreement we intend to broaden our promotion of the ICL as a solution that provides excellent visual results to our patients.”
“Kobe Kanagawa Eye Clinic is one of the largest refractive eye surgery providers in Japan, an increasingly important market for our ICL lenses, and we are thrilled to announce this strategic cooperation agreement,” Caren Mason, President & CEO of Staar, said in the news release. “Dr. Yoshihiro Kitazawa, Chief Medical Director of the clinic, was a recipient of our ICL Ambassador Award in 2017 and holds Staar’s ‘Expert Instructor’ training and education designation. The clinic has treated many celebrity patients. We look forward to working even more closely with the Kobe Kanagawa team to achieve excellent vision for patients with the EVO Visian ICL family of lenses.”